GO:0008625 extrinsic apoptotic signaling pathway via death domain receptors: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008625 describes the cell-surface-to-apoptosis signaling cascade initiated when a ligand binds a death domain receptor, ending with activation of the execution phase of apoptosis.
• Core components include death receptors such as TNFRSF10A/TRAIL-R1, TNFRSF10B/TRAIL-R2, FAS, and TNFRSF1A, together with adaptors FADD and TRADD and initiator caspases CASP8 and CASP10.
• The pathway is tightly controlled by E3 ubiquitin ligases and deubiquitinases that modulate receptor stability and downstream caspase activation.
• Dysregulated death receptor signaling contributes to cancer progression, including pancreatic ductal adenocarcinoma, and to chemotherapy resistance.
• Death receptor-mediated apoptosis is conserved across vertebrates, as shown by core component conservation in Medaka fish.
• Experimental dissection relies on CRISPR knockout, point-mutation, knock-in, overexpression models combined with apoptosis assays, transcriptomics, and proteomics.
Description
The extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) is the series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell, starting with ligand binding to a death domain receptor and ending when the execution phase of apoptosis is triggered. This pathway is a central mechanism by which extracellular cues, including immune cytokines and death ligands, are translated into programmed cell death, and it is therefore a major focus in cancer biology, immunology, and toxicology. Death receptor signaling is initiated by ligands such as TNF-related apoptosis-inducing ligand (TRAIL), Fas ligand, and TNF-alpha, which engage receptors including TNFRSF10A, TNFRSF10B, FAS, and TNFRSF1A. The pathway is conserved across vertebrates, as demonstrated by the evolutionary conservation of core components necessary for extrinsic apoptotic signaling in Medaka fish. Because death receptor signaling can be modulated at multiple levels, including receptor ubiquitination and microRNA regulation, it represents a tractable target for therapeutic intervention and for mechanistic studies using CRISPR-based cell models. Researchers studying this pathway require reliable, publication-grade experimental systems to determine how individual genes causally affect apoptosis sensitivity and resistance.
extrinsic apoptotic signaling pathway via death domain receptors At A Glance
| GO ID | GO:0008625 |
|---|---|
| GO term | extrinsic apoptotic signaling pathway via death domain receptors |
| Ontology | biological_process |
| Synonym | death receptor-mediated apoptosis; induction of apoptosis via death domain receptors; induction of apoptosis via death receptors |
| Major function | Transduces extracellular death ligand signals from cell surface death domain receptors to trigger the execution phase of apoptosis |
| Key receptors | TNFRSF10A, TNFRSF10B, FAS, TNFRSF1A |
| Key adaptors and caspases | FADD, TRADD, CASP8, CASP10 |
| Regulatory layer | E3 ubiquitin ligases and deubiquitinases modulate TRAIL-mediated extrinsic apoptotic signaling |
| Evolutionary conservation | Core components are conserved in Medaka fish |
What Is GO:0008625?
GO:0008625, extrinsic apoptotic signaling pathway via death domain receptors, is defined as the series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface and ends when the execution phase of apoptosis is triggered. Synonyms include death receptor-mediated apoptosis, induction of apoptosis via death domain receptors, and induction of apoptosis via death receptors.
Why Is extrinsic apoptotic signaling pathway via death domain receptors Important in Cell Biology?
GO:0008625 is important because death receptor-mediated apoptosis is a primary mechanism for eliminating damaged, infected, or transformed cells, and its dysregulation is directly linked to cancer, immune evasion, and resistance to therapy. In pancreatic ductal adenocarcinoma, death receptor signaling impacts malignancy and influences tumor cell survival. In aged skeletal muscle, death receptor-associated pro-apoptotic signaling contributes to tissue degeneration. Environmental toxins such as aflatoxin B1 can invoke apoptosis via the death receptor pathway in hepatocytes, linking this GO term to toxicological outcomes. Moreover, death receptor signaling intersects with programmed necrosis and antiviral host defense, expanding its relevance beyond classical apoptosis. Because the pathway is amenable to precise genetic perturbation, it is a prime target for CRISPR-based functional genomics and for developing therapeutics that cluster death receptors to induce dual cell death pathways.
• Central to cancer biology: death receptor signaling influences tumor malignancy and chemoresistance, notably in pancreatic ductal adenocarcinoma.
• Mediates TRAIL-induced apoptosis, a major target for anticancer therapeutics.
• Regulated by microRNAs that control cancer cell death pathways including apoptosis and necroptosis.
• Contributes to age-related muscle degeneration through death receptor-associated pro-apoptotic signaling.
• Involved in hepatocyte apoptosis triggered by aflatoxin B1, linking the pathway to environmental toxicology.
• Crosstalks with programmed necrosis in antiviral host defense and inflammation.
• Can be therapeutically engaged by nanoagonists that cluster death receptors to induce dual cell death pathways.
• Evolutionarily conserved core components enable comparative studies in model organisms such as Medaka fish.
• Provides a tractable system for CRISPR knockout, knock-in, and overexpression studies of apoptosis regulators.
What Happens During extrinsic apoptotic signaling pathway via death domain receptors?
Ligand binding and receptor activation
In simple terms: A death ligand outside the cell binds to a death receptor on the cell surface, switching the receptor on.
The pathway begins when ligands such as TRAIL, Fas ligand, or TNF-alpha bind to death domain receptors including TNFRSF10A, TNFRSF10B, FAS, and TNFRSF1A. This binding induces receptor trimerization or clustering, which is a prerequisite for recruitment of intracellular adaptor proteins. In cancer therapy, self-illuminating nanoagonists have been designed to simultaneously induce dual cell death pathways via death receptor clustering. The activated receptor complex serves as a platform for assembly of the death-inducing signaling complex (DISC).
DISC assembly and initiator caspase activation
In simple terms: Inside the cell, adaptor proteins and initiator caspases gather at the receptor to form a signaling platform.
Upon receptor activation, the adaptor protein FADD is recruited, which in turn recruits initiator caspases such as CASP8 and CASP10 to form the DISC. TRADD can also participate in signaling downstream of TNFRSF1A. The proximity of caspase molecules within the DISC promotes their activation through dimerization and cleavage. This step is a key regulatory node, as E3 ubiquitin ligases and deubiquitinases can modulate the stability and activity of DISC components, thereby influencing TRAIL-mediated extrinsic apoptotic signaling.
Execution phase of apoptosis
In simple terms: The initiator caspases activate executioner caspases that dismantle the cell.
Active CASP8 and CASP10 cleave and activate downstream effector caspases, such as CASP3 and CASP7, which execute the apoptotic program by cleaving structural and regulatory proteins. This execution phase represents the endpoint of GO:0008625, as defined by the QuickGO definition. The pathway can be amplified through mitochondrial involvement in some cell types, but the core death receptor-mediated route proceeds through direct caspase activation. MicroRNAs can regulate this execution phase by targeting components of the apoptosis machinery.
Regulation by ubiquitination and deubiquitination
In simple terms: Tagging proteins with ubiquitin or removing those tags controls how strongly the death signal flows.
E3 ubiquitin ligases and deubiquitinases act as modulators of TRAIL-mediated extrinsic apoptotic signaling by adding or removing ubiquitin chains on receptors, adaptors, and caspases. This regulation can determine whether a cell survives or dies in response to death ligands. For example, ubiquitination of CASP8 or receptor components can alter DISC stability and downstream caspase activation. This layer of control is critical for understanding resistance to TRAIL-based therapies and for identifying druggable targets.
Crosstalk with necroptosis and inflammatory signaling
In simple terms: The death receptor pathway can also trigger a different form of cell death called necroptosis, especially during antiviral responses.
Death receptor signaling is not exclusively apoptotic; it can crosstalk with programmed necrosis (necroptosis) in antiviral host defense, inflammation, and immunogenicity. This crosstalk is mediated by shared components such as RIPK1 and RIPK3, and it influences the outcome of infection and immune activation. MicroRNAs also regulate the balance between apoptosis and necroptosis in cancer cells. Understanding this crosstalk is essential for interpreting experimental results when perturbing GO:0008625 components.
Key Genes Involved in GO:0008625 extrinsic apoptotic signaling pathway via death domain receptors
The following genes and proteins are core components or well-documented regulators of the extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625).
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFRSF10A | Death receptor for TRAIL (TRAIL-R1) | Target for TRAIL-based cancer therapy; receptor clustering studies |
| TNFRSF10B | Death receptor for TRAIL (TRAIL-R2) | Key mediator of extrinsic apoptosis; ubiquitination-regulated |
| FAS | Death receptor for Fas ligand | Model receptor for DISC assembly and apoptosis signaling |
| TNFRSF1A | Death receptor for TNF-alpha | Links inflammation to apoptosis and necroptosis |
| FADD | Adaptor protein recruiting CASP8 to DISC | Essential for initiator caspase activation |
| TRADD | Adaptor protein for TNFRSF1A signaling | Mediates TNF-induced apoptosis and NF-kB crosstalk |
| CASP8 | Initiator caspase activated at DISC | Central executioner of death receptor apoptosis |
| CASP10 | Initiator caspase in DISC | Modulates apoptosis sensitivity in cancer cells |
| CASP3 | Effector caspase | Executes apoptosis downstream of CASP8 |
| CASP7 | Effector caspase | Amplifies caspase cascade |
| RIPK1 | Kinase mediating necroptosis crosstalk | Determines apoptosis versus necroptosis outcome |
| RIPK3 | Kinase essential for necroptosis | Crosstalk with death receptor signaling |
| BID | BH3-only protein linking extrinsic to intrinsic apoptosis | Amplification of death receptor signaling |
| CFLAR | Caspase-8 inhibitor (FLIP) | Regulates DISC-mediated caspase activation |
| BIRC5 | Survivin, inhibitor of apoptosis | Modulates apoptosis resistance |
| XIAP | Inhibitor of apoptosis protein | Regulates caspase activity |
| TNF | Ligand for TNFRSF1A | Initiates inflammatory and apoptotic signaling |
| FASLG | Ligand for FAS | Triggers FAS-mediated apoptosis |
How Is extrinsic apoptotic signaling pathway via death domain receptors Regulated?
The extrinsic apoptotic signaling pathway via death domain receptors is regulated at multiple levels. E3 ubiquitin ligases and deubiquitinases directly modulate TRAIL-mediated extrinsic apoptotic signaling by controlling the ubiquitination status of receptors, adaptors, and caspases. MicroRNAs regulate cancer cell death pathways, including apoptosis and necroptosis, by targeting components of the death receptor machinery. The pathway also crosstalks with programmed necrosis, where RIPK1 and RIPK3 kinase activity can shift the cellular response from apoptosis to necroptosis depending on context. Additionally, death receptor signaling impacts malignancy in pancreatic ductal adenocarcinoma, suggesting that tumor-specific regulatory mechanisms modulate pathway output. In aged skeletal muscle, death receptor-associated pro-apoptotic signaling is upregulated, indicating age-related regulatory changes.
extrinsic apoptotic signaling pathway via death domain receptors and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFRSF10B | Cancer (TRAIL resistance) | CRISPR knockout in cancer cell lines followed by TRAIL treatment |
| CASP8 | Cancer (apoptosis evasion) | Point mutation knock-in to assess catalytic activity |
| FADD | Cancer and immune disorders | Knockout in Jurkat or HeLa cells |
| RIPK1 | Antiviral defense and inflammation | Knock-in of kinase-dead mutant |
| TNFRSF1A | Inflammatory disease | Overexpression in HEK293T cells |
Cancer and therapy resistance
Dysregulation of death receptor signaling is a hallmark of many cancers. In pancreatic ductal adenocarcinoma, death receptor signaling impacts malignancy, and alterations in this pathway contribute to aggressive tumor behavior and resistance to apoptosis. TRAIL-mediated extrinsic apoptotic signaling is a major target for anticancer therapy, but cancer cells often evade it through ubiquitination-dependent mechanisms and microRNA-mediated regulation. Self-illuminating nanoagonists that cluster death receptors have been developed to simultaneously induce dual cell death pathways for cancer therapy, highlighting the therapeutic potential of targeting GO:0008625.
Toxicology and liver injury
Environmental toxins can trigger death receptor-mediated apoptosis. Aflatoxin B1 invokes apoptosis via the death receptor pathway in hepatocytes, linking GO:0008625 to toxic liver injury and hepatocellular damage. This connection is important for understanding how xenobiotics induce apoptosis and for developing protective strategies.
Neurodegeneration and aging
Death receptor-associated pro-apoptotic signaling is elevated in aged skeletal muscle, contributing to sarcopenia and tissue degeneration. Although the provided citations focus on skeletal muscle, the involvement of death receptors in age-related cell loss suggests broader relevance to degenerative conditions. Researchers can use this pathway to study how aging modulates apoptosis sensitivity.
Infectious disease and inflammation
Death receptor signaling crosstalks with programmed necrosis in antiviral host defense, inflammation, and immunogenicity. This crosstalk determines whether infected cells undergo apoptosis or necroptosis, influencing pathogen clearance and immune activation. Understanding these mechanisms is critical for developing therapies against viral infections and inflammatory diseases.
From extrinsic apoptotic signaling pathway via death domain receptors-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TNFRSF10B confer TRAIL resistance? | CRISPR knockout in cancer cell lines |
| Does a specific CASP8 mutation alter DISC formation? | Point mutation knock-in |
| Can a tagged FADD knock-in reveal DISC dynamics? | Tagged knock-in (e.g., GFP-FADD) |
| Does overexpression of CFLAR block apoptosis? | Overexpression cell model |
| Which E3 ligases regulate TRAIL-induced apoptosis? | CRISPR library screening |
| Does RIPK1 kinase activity determine apoptosis versus necroptosis? | Knock-in of kinase-dead RIPK1 |
How to Study the extrinsic apoptotic signaling pathway via death domain receptors Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis after TRAIL treatment |
| Caspase-3/7 activity assay | Effector caspase activity | Measure execution phase activation |
| RNA-seq | Transcriptome changes | Identify genes regulated by death receptor signaling |
| MicroRNA profiling | MicroRNA expression | Discover regulators of apoptosis and necroptosis |
| Ubiquitination assay | Protein ubiquitination status | Study E3 ligase/deubiquitinase modulation |
| Immunoprecipitation | Protein-protein interactions | Analyze DISC composition |
| Live-cell imaging | Receptor clustering dynamics | Visualize death receptor activation |
| CRISPR library screening | Gene essentiality in apoptosis | Identify novel regulators of GO:0008625 |
Apoptosis assays
Annexin V staining, caspase activity assays, and TUNEL staining are standard methods to measure apoptosis induced by death receptor ligands. These assays quantify the endpoint of GO:0008625 and are used to validate CRISPR perturbations.
Transcriptomics and microRNA profiling
RNA sequencing and microRNA profiling reveal changes in gene expression following death receptor activation or genetic perturbation. These methods help identify regulatory networks involving microRNAs that modulate apoptosis and necroptosis.
Proteomics and ubiquitination analysis
Mass spectrometry-based proteomics and ubiquitination assays can identify post-translational modifications on death receptor pathway components. These approaches are essential for understanding how E3 ligases and deubiquitinases regulate TRAIL-mediated signaling.
Imaging and receptor clustering
Live-cell imaging and fluorescence microscopy can visualize death receptor clustering and DISC formation in real time. Self-illuminating nanoagonists have been used to induce and monitor receptor clustering for cancer therapy.
How CRISPR Can Be Used to Study GO:0008625 extrinsic apoptotic signaling pathway via death domain receptors
Knockout
CRISPR knockout of death receptor genes such as TNFRSF10B or adaptors like FADD can abolish TRAIL-induced apoptosis, providing causal evidence for their role in GO:0008625. Knockout cell models are essential for validating drug targets and understanding resistance mechanisms.
Point Mutation
Point mutation knock-in can be used to dissect catalytic residues in CASP8 or phosphorylation sites in RIPK1, revealing how specific amino acids control apoptosis versus necroptosis. These models are critical for understanding the molecular mechanism of the pathway.
Knock-in
Tagged knock-in of FADD or CASP8 allows real-time tracking of DISC assembly and caspase activation in live cells. Knock-in of reporter genes can also be used to monitor pathway activity in high-throughput screens.
Overexpression
Overexpression of anti-apoptotic proteins such as CFLAR or BIRC5 can block death receptor-mediated apoptosis, helping to identify resistance factors. Conversely, overexpression of pro-apoptotic components can sensitize cells to TRAIL.
How EDITGENE Supports extrinsic apoptotic signaling pathway via death domain receptors Research
Researchers studying extrinsic apoptotic signaling pathway via death domain receptors-related genes often need to determine whether a candidate gene is causally involved in apoptosis sensitivity, resistance, or crosstalk with other cell death modalities. EDITGENE provides publication-grade CRISPR cell models and screening services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for extrinsic apoptotic signaling pathway via death domain receptors research.
Frequently Asked Questions About extrinsic apoptotic signaling pathway via death domain receptors
What is GO:0008625?
GO:0008625 is the Gene Ontology term for extrinsic apoptotic signaling pathway via death domain receptors, defined as the series of molecular signals from cell surface death domain receptor ligation to the triggering of apoptosis execution.
What genes are involved in extrinsic apoptotic signaling pathway via death domain receptors?
Key genes include TNFRSF10A, TNFRSF10B, FAS, TNFRSF1A, FADD, TRADD, CASP8, CASP10, and regulators such as CFLAR and BIRC5.
How is death receptor-mediated apoptosis regulated?
It is regulated by E3 ubiquitin ligases and deubiquitinases, microRNAs, and crosstalk with necroptosis kinases such as RIPK1 and RIPK3.
What diseases are associated with death receptor signaling?
Diseases include cancer (e.g., pancreatic ductal adenocarcinoma), toxin-induced liver injury, age-related muscle degeneration, and inflammatory or infectious conditions.
How can I study GO:0008625 in the lab?
Common methods include apoptosis assays, RNA-seq, microRNA profiling, ubiquitination assays, immunoprecipitation, live-cell imaging, and CRISPR screening.
What is the role of CASP8 in death receptor apoptosis?
CASP8 is an initiator caspase recruited to the DISC, where it becomes activated and cleaves downstream effector caspases to execute apoptosis.
Can CRISPR knockout be used to study death receptor pathway genes?
Yes, CRISPR knockout of genes like TNFRSF10B or FADD is a standard approach to test their requirement for death receptor-mediated apoptosis.
What is the difference between apoptosis and necroptosis in this pathway?
Apoptosis is caspase-dependent cell death, while necroptosis is a programmed necrosis mediated by RIPK1/RIPK3; death receptor signaling can trigger either depending on context.
Is the extrinsic apoptotic pathway conserved across species?
Yes, core components necessary for extrinsic apoptotic signaling are conserved in vertebrates such as Medaka fish.
How does aflatoxin B1 induce apoptosis?
Aflatoxin B1 invokes apoptosis via the death receptor pathway in hepatocytes, linking environmental toxins to GO:0008625.
Conclusion
GO:0008625, extrinsic apoptotic signaling pathway via death domain receptors, is a fundamental biological process that translates extracellular death signals into programmed cell death. Its core components, including death receptors, adaptors, and caspases, are conserved across vertebrates and are tightly regulated by ubiquitination, microRNAs, and crosstalk with necroptosis. Dysregulation of this pathway is implicated in cancer, toxicology, aging, and infectious disease, making it a high-value target for both basic and translational research. CRISPR-based cell models and screening approaches provide powerful tools to dissect the causal roles of individual genes in this pathway, and EDITGENE offers comprehensive services to support such studies.
References
- 1. Woo SM et al.. 2019. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.. BMB Rep 52(2):119-126 PMID: 30638181
- 2. Röder C et al.. 2011. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.. Eur J Cell Biol 90(6-7):450-5 PMID: 21129814
- 3. Pistilli EE et al.. 2006. Death receptor-associated pro-apoptotic signaling in aged skeletal muscle.. Apoptosis 11(12):2115-26 PMID: 17051337
- 4. Shirjang S et al.. 2019. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.. Free Radic Biol Med 139:1-15 PMID: 31102709
- 5. Mughal MJ et al.. 2017. Aflatoxin B1 invokes apoptosis via death receptor pathway in hepatocytes.. Oncotarget 8(5):8239-8249 PMID: 28030812
- 6. Mocarski ES et al.. 2014. True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.. J Immunol 192(5):2019-26 PMID: 24563506
- 7. You Y et al.. 2024. Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy.. ACS Nano 18(26):17119-17134 PMID: 38912613
- 8. Sakamaki K et al.. 2007. The evolutionary conservation of the core components necessary for the extrinsic apoptotic signaling pathway, in Medaka fish.. BMC Genomics 8:141 PMID: 17540041
